Multicenter evaluation of an MIC-based aztreonam and ceftazidime-avibactam broth disk elution test

H Harris, L Tao, EB Jacobs, Y Bergman… - Journal of clinical …, 2023 - Am Soc Microbiol
Due to limited therapeutic options, there is a clinical need to assess the in vitro activity of the
combination of aztreonam (ATM) and ceftazidime-avibactam (CZA) to guide the therapeutic …

Safety of ceftazidime-avibactam in combination with aztreonam (COMBINE) in a phase I, open-label study in healthy adult volunteers

TP Lodise, JN O'Donnell, S Raja… - Antimicrobial agents …, 2022 - Am Soc Microbiol
This phase I study evaluated the safety of the optimal ceftazidime-avibactam (CZA) with
aztreonam (ATM) regimens identified in hollow fiber infection models of MBL-producing …

Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coli

N Helsens, M Sadek, C Le Terrier, L Poirel… - European Journal of …, 2024 - Springer
Abstract Purpose Carbapenemase-producing Enterobacterales are a growing threat, and
very few therapeutic options remain active against those multidrug resistant bacteria …

Assessment of broth disk elution method for aztreonam in combination with ceftazidime/avibactam against Enterobacterales isolates

P Song, J Xu, L Jiang, Q Zhang, C Liu - Microbiology Spectrum, 2024 - journals.asm.org
The combination of aztreonam with ceftazidime/avibactam is considered a potential
therapeutic approach for the treatment of infections caused by metallo-β-lactamase (MBL) …

OXA-23-producing Acinetobacter baumannii isolates in L. Pasteur University Hospital in Slovakia from September 2021 to December 2021

B Dzugasová, L Siegfried, V Hrabovský, K Čurová… - Biologia, 2022 - Springer
Carbapenem-resistant Acinetobacter baumannii (CRAB) has been associated with hospital-
acquired infections. A variety of methods for rapid detection of CRAB have been developed …